| Copper deficiency anemia ZW Myint, TH Oo, KZ Thein, AM Tun, H Saeed Annals of hematology 97, 1527-1534, 2018 | 258 | 2018 |
| 9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy G Han, G Yang, D Hao, Y Lu, K Thein, BS Simpson, J Chen, R Sun, ... Nature communications 12 (1), 5606, 2021 | 96 | 2021 |
| Precision therapy for RET-altered cancers with RET inhibitors KZ Thein, V Velcheti, BHM Mooers, J Wu, V Subbiah Trends in cancer 7 (12), 1074-1088, 2021 | 95 | 2021 |
| Adverse effects of immune checkpoint therapy in cancer patients visiting the emergency department of a comprehensive cancer center I El Majzoub, A Qdaisat, KZ Thein, MA Win, MM Han, K Jacobson, ... Annals of emergency medicine 73 (1), 79-87, 2019 | 84 | 2019 |
| Acute symptomatic hypocalcemia from immune checkpoint therapy-induced hypoparathyroidism MA Win, KZ Thein, A Qdaisat, SCJ Yeung The American Journal of Emergency Medicine 35 (7), 1039. e5-1039. e7, 2017 | 80 | 2017 |
| Therapeutics targeting mutant KRAS KZ Thein, AB Biter, DS Hong Annual review of medicine 72, 349-364, 2021 | 51 | 2021 |
| The contemporary management of cancers of the sinonasal tract in adults R Thawani, MS Kim, A Arastu, Z Feng, MT West, NF Taflin, KZ Thein, R Li, ... CA: a cancer journal for clinicians 73 (1), 72-112, 2023 | 45 | 2023 |
| Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers B Garmezy, J Gheeya, HY Lin, Y Huang, T Kim, X Jiang, KZ Thein, ... JCO Precision Oncology 6, e2100267, 2022 | 41 | 2022 |
| Venous thromboembolism risk in patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with combined CDK 4/6 inhibitors plus endocrine therapy … KZ Thein, TW Htut, S Ball, S Swarup, A Sultan, TH Oo Breast Cancer Research and Treatment 183, 479-487, 2020 | 39 | 2020 |
| Pernicious anemia: Pathophysiology and diagnostic difficulties TW Htut, KZ Thein, TH Oo Journal of Evidence‐Based Medicine 14 (2), 161-169, 2021 | 31 | 2021 |
| Checkpoint inhibitors plus chemotherapy for first-line treatment of advanced non-small cell lung cancer: a systematic review and meta-analysis of randomized controlled trials AM Tun, KZ Thein, WL Thein, E Guevara Future science OA 5 (9), FSO421, 2019 | 28 | 2019 |
| Thrombosis in Philadelphia negative classical myeloproliferative neoplasms: a narrative review on epidemiology, risk assessment, and pathophysiologic mechanisms S Ball, KZ Thein, A Maiti, K Nugent Journal of Thrombosis and Thrombolysis 45, 516-528, 2018 | 26 | 2018 |
| Primary thromboprophylaxis (PTP) in ambulatory patients with lung cancer receiving chemotherapy: A systematic review and meta‐analysis of randomized controlled trials (RCTs) KZ Thein, SCJ Yeung, TH Oo Asia‐Pacific Journal of Clinical Oncology 14 (3), 210-216, 2018 | 23 | 2018 |
| First‐in‐human, phase I/IIa study of CRLX301, a nanoparticle drug conjugate containing docetaxel, in patients with advanced or metastatic solid malignancies SA Piha-Paul, KZ Thein, P De Souza, R Kefford, T Gangadhar, C Smith, ... Investigational New Drugs 39, 1047-1056, 2021 | 21 | 2021 |
| A rare concurrence of leiomyomatosis peritonealis disseminata, leiomyosarcoma of the pelvis and leiomyomatous nodule of the liver AM Tun, NM Tun, K Zin Thein, EE Naing, S Giashuddin, M Shulimovich Case Reports in Oncological Medicine 2016, 2016 | 21 | 2016 |
| Tissue-agnostic drug development: a new path to drug approval KZ Thein, SJ Lemery, S Kummar Cancer discovery 11 (9), 2139-2144, 2021 | 19 | 2021 |
| Incidence of cardiac toxicities in patients with advanced non-small cell lung cancer treated with osimertinib: a combined analysis of two phase III randomized controlled trials KZ Thein, S Swarup, S Ball, M Quirch, Y Vorakunthada, KK Htwe, ... Annals of Oncology 29, viii500, 2018 | 19 | 2018 |
| Immunotherapy in head and neck squamous cell carcinoma: An updated review K Parmar, A Mohamed, E Vaish, R Thawani, J Cetnar, KZ Thein Cancer Treatment and Research Communications 33, 100649, 2022 | 18 | 2022 |
| Correlation of pathogenic POLE mutations with clinical benefit to immune checkpoint inhibitor therapy. B Garmezy, JS Gheeya, KZ Thein, PG Pilie, W Wang, J Rodon Ahnert, ... Journal of Clinical Oncology 38 (15_suppl), 3008-3008, 2020 | 15 | 2020 |
| Pernicious anemia: fundamental and practical aspects in diagnosis AM Tun, KZ Thein, ZW Myint, TH Oo Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly …, 2017 | 15 | 2017 |
Sriman SwarupNorthern Light Health (Attending Hematologist/Oncologist). TTUHSC (Adjunct Asst Professor)Verified email at ttuhsc.edu
